Wednesday, September 7, 2016

Retrophin's kidney drug succeeds in mid-stage study

Sept 7 (Reuters) - Retrophin Inc said its rare

kidney disorder drug met the main goal of a mid-stage study.

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)